Keywords: AYA; adolescent and young adult; GCT; germ cell tumor; MOGCT; malignant ovarian germ cell tumor; MaGIC; Malignant Germ Cell Tumor International Consortium; U.S.; United States; U.K.; United Kingdom; CTOs; Clinical Trial Organizations; COG, United States,
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Squamous cell carcinoma; Vulva; Surgery; Resection margin; Recurrence rate; FIGO; International Federation of Gynaecology and Obstetrics; GOCS; Gynecological Oncology Center South; HPV; Human Papilloma Virus; HSIL; High-grade squamous intraepithelial lesi
Keywords: SCC; squamocellular cervical cancer; CIN; cervical intraepithelial neoplasia; IFCPC; International Federation for Cervical Pathology and Colposcopy; HIV; Human Immunodeficiency Virus; HSIL; High-grade Squamous Intraepithelial Lesion; ASC-H; atypical squam
Keywords: 3D-CRT; three-dimensional conformal radiation therapy; AP-PA; anteroposterior and posteroanterior fields; BMI; body mass index; CI; confidence interval; CTC-AE; Common Terminology Criteria for Adverse Events; DM; diabetes mellitus; EBRT; external beam rad
Keywords: Pelvic DWI-MRI; Endometrial lesions; ADC value; DW-MRI; diffusion-weighted MRI; ADC; apparent diffusion coefficient; PPV; positive predictive value; NPV; negative predictive value; FIGO; International Federation of Gynecology and Obstetrics;
Keywords: OCCC; Ovarian clear cell carcinoma; RFS; recurrence-free survival; OS; overall survival; FIGO; Federation of Gynecology and Obstetrics; WHO; World Health Organization; LVSI; Lymphovascular space invasion; EAOC; Endometriosis-associated ovarian carcinoma;
Keywords: ASA; American Society of Anesthesiologists; CSS; cause-specific survival; EC; endometrial cancer; FIGO; International Federation of Gynecology and Obstetrics; GOG; Gynecologic Oncology Group; HR; hazard ratio; JGOG; Japanese Gynecologic Oncology Group; PF
Keywords: Apparent diffusion coefficient (ADC); Cervical cancer; FIGO
Keywords: FIGO; staging; vulvar cancer
Keywords: FIGO; International Federation of Gynecology and Obstetrics; MCR; Manitoba Cancer Registry; HR; hazard ratio; CI; confidence interval; CrI; credible interval; ECOG; Eastern Cooperative Oncology Group; NCI; National Cancer Institute; BCCA; British Columbia
Keywords: staging; MRI; PET/CT; radiology; FIGO; CCRT
Keywords: Low-resource setting; FIGO; Maternal mortality; Millennium Development Goals
Keywords: ICC; invasive cervical cancer; OCSP; organized cervical screening program; CR; Cancer Registry; ICD; International Classification of Diseases; NOS; not otherwise specified; OR; odds ratio; HR; hazard ratio; CI; confidence interval; FIGO; International Fed
Keywords: CCC; clear cell carcinoma; EC; endometrial cancer; FIGO; International Federation of Gynecology and Obstetrics; GOG; Gynecologic Oncology Group; G3EC; grade 3 endometrioid carcinoma; HR; hazard ratio; LND; lymphadenectomy; LVSI; lymphovascular space invol
Keywords: EC; endometrial cancer; FIGO; Fédération Internationale de Gynécologie et d'Obstétrique (International Federation of Gynecology and Obstetrics); Bone; Endometrial neoplasms; Neoplasm metastases; Osseous; Prognosis;
Aggressive neuroendocrine tumor of the ovary with multiple metastases treated with everolimus: A case report
Keywords: Carcinoid; Everolimus; Multiple metastases; Neuroendocrine tumor; Ovary; NETs; neuroendocrine tumors; FIGO; International Federation of Gynecology and Obstetrics; mTOR; mammalian target of rapamycin; MRI; magnetic resonance imaging; CT; computed tomograph
A multidisciplinary approach to oncology trials: Study conduct of the ANTHALYA trial
Keywords: Clinical trial conduct; Bayesian inference; Electronic case report form; Safety; Multidisciplinary; AE; adverse events; AUC; area under the curve; BCP; bevacizumab, carboplatin and paclitaxel; CP; carboplatin and paclitaxel; CRA; clinical research associa
Long non-coding RNA PVT1-5 promotes cell proliferation by regulating miR-126/SLC7A5 axis in lung cancer
Keywords: Lung cancer; lncRNA-PVT1-5; miR-126; SLC7A5; Competing endogenous RNA; LncRNAs; long non-coding RNAs; miRNAs; microRNAs; PVT1; plasmacytoma variant translocation 1; miRIP; miRNA in vivo precipitation; ceRNA; competing endogenous RNA; TUG1; taurine-upregu
Metabolomic profiling suggests long chain ceramides and sphingomyelins as a possible diagnostic biomarker of epithelial ovarian cancer
Keywords: EOC; Epithelial ovarian cancer; HPLC-TQ/MS; High performance liquid chromatography-triple quadruple/mass spectrometry; AUC; area under curve; OC; ovarian cancer; BMI; body mass index; PLS-DA; partial least square discriminant analysis; VIP; variable i
Prognostic Factors in Patients Undergoing Primary Cytoreductive Surgery for FIGO Stage IIIC Ovarian, Tubal or Peritoneal Cancer
Keywords: Primary surgery; upper abdominal metastasis; cytoreduction; FIGO;
Membrane progesterone receptors β and γ have potential as prognostic biomarkers of endometrial cancer
Keywords: EC; endometrial cancer; mPR; membrane progesterone receptors; PAQR; adipoQ receptor; qPCR; quantitative real-time PCR; FIGO; International Federation of Gynecology and Obstetrics; TMA; tissue microarrays;; MAPK; mitogen-activated protein kinases; Membrane
No 292-Saignements utérins anormaux chez les femmes préménopausées
Keywords: Menorrhagia; heavy menstrual bleeding; abnormal uterine bleeding; hysterectomy; endometrial ablation; AINS; anti-inflammatoires non stéroïdiens; AMP; acétate de médroxyprogestérone; AMPR; acétate de médroxyprogestérone-retard; β-hCG; bêta-gonado
Aptamers as potential therapeutic agents for ovarian cancer
Keywords: Aptamers; Antibodies; EpCAM; Therapeutic; Targeted therapies; Ovarian cancer; ADCC; antibody-dependent cell-mediated cytotoxicity; ABC; ATP-binding cassette; BBB; blood brain barrier; CDC; complement-mediated cytolysis; CA125; Cancer Antigen 125; CSCs; ca
Invasive vulval cancer
Keywords: chemotherapy; FIGO; invasive; prognosis; radiotherapy; vulval cancer; wide local excision;
Searching for new biomarkers in ovarian cancer patients: Rationale and design of a retrospective study under the Mermaid III project
Keywords: Ovarian cancer; Diagnostic/prognostic biomarkers; MicroRNA; Epigenetics; Next Generation Sequencing; OC; Ovarian cancer; FIGO; International Federation of Gynecology and Obstetrics; CA125; Cancer Antigen 125; RMI; Risk of Malignancy Index; DGCD; Danish Gy
Clinical significance and prognostic value of femoral lymph node metastasis in FIGO stage III vulvar carcinoma
Keywords: Vulvar cancer; FIGO; Lymph node; Femoral; Inguinal; Metastasis;
MR Imaging of Cervical Cancer
Keywords: Cervical cancer; MR imaging; PET/CT; Staging; FIGO;
No 344-Salpingectomie opportuniste et autres méthodes pour réduire le risque de cancer de l'ovaire, de la trompe de Fallope et du péritoine dans la population générale
Keywords: néoplasmes séreux de l'ovaire; néoplasmes de la trompe de Fallope; salpingectomie; prévention primaire; AAS; Acide acétylsalicylique; BRCA; Gène du cancer du sein; CEO; Cancer épithélial de l'ovaire; CO; Contraceptif oral; CSGE; Cancer séreux de
Role of rs13117307 single nuclear polymorphism in the risk of uterine cervical cancer from Polish population and its impact on exocyst complex component 1 expression
Keywords: EXCO1; exocyst complex component 1; SCC; cervical squamous cell carcinoma; n; number; SNP; single nucleotide polymorphism; OR; odds ratio; CT; cervical tumors; MHC; Major histocompatibility complex; GWAS; Genome-wide association studies; HRM; high-resolut
Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and ovarian cancer in Polish women
Keywords: CI; Confidence interval; DSBs; Double-stranded breaks; FIGO; International Federation of Gynaecology and Obstetrics; FFPE; Formalin-fixed paraffin-embedded; HWE; Hardy-Weinberg equilibrium; OR; Odds ratio; PCR-RFLP; Polymerase chain reaction-Restriction
Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: The MITO-9 study
Keywords: GCTs; granulosa cell tumors; BEP; bleomycin, etoposide and cisplatin; FIGO; International Federation of Gynecology and Obstetrics; MITO; Multicenter Italian Trials in Ovarian cancer; DFS; disease free survival; OS; overall survival; TTR1; time to first re
Y-box protein-1/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank Ovarian Cancer (TOC)
Keywords: CA125; carbohydrate antigen 125; CI; confidence interval; CSD; cold shock domain; EOC; epithelial ovarian cancer; FIGO; International Federation of Gynecology and Obstetrics; GCIC; Gynecological Cancer Intergroup; HE4; human epididymis protein 4; HGSOC; h
Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome
Keywords: FIGO; International Federation of Gynecology and Obstetrics; HG-SOC; high-grade serous ovarian cancer; OS; overall survival; PFS; progression-free survival; TMA; tissue microarray;
Prise en charge des léiomyomes utérins
Keywords: Myoma; leiomyoma; fibroid; myomectomy; uterine artery embolization; hysterectomy; heavy menstrual bleeding; menorrhagia; AAGL; American Association of Gynecologic Laparoscopists; AE; ablation de l'endomètre; ANET; acétate de noréthindrone; AUP; acétat
Saignements utérins anormaux chez les femmes préménopausées
Keywords: Menorrhagia; heavy menstrual bleeding; abnormal uterine bleeding; hysterectomy; endometrial ablation; AINS; anti-inflammatoires non stéroïdiens; AMP; acétate de médroxyprogestérone; AMPR; acétate de médroxyprogestérone-retard; Ã-hCG; bêta-gonado
Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists
Keywords: AUB; abnormal uterine bleeding; BMI; body mass index; DVT; deep-vein thrombosis; FIGO; International Federation of Gynecology and Obstetrics; IQR; interquartile range; LMWH; low-molecular-weight heparin; DOAC; direct-acting oral anticoagulant; PE; pulmona
Is the endometrial evaluation routinely required in patients with adult granulosa cell tumors of the ovary?
Keywords: GCT; granulosa cell tumor; MITO; Multicenter Italian Trials in Ovarian Cancer; FIGO; International Federation of Gynecology and Obstetrics; US; ultrasound; WHO; The World Health Organization; IGF; insulin-like growth factor; IGF-BPs; insulin-like growth f
Facing the noncommunicable disease (NCD) global epidemic – The battle of prevention starts in utero – The FIGO challenge
Keywords: NCDs; fetal programming; epigenetics; FIGO; DOHaD; diabetes mellitus
MRI for local staging of endometrial carcinoma: Is endovenous contrast medium administration still needed?
Keywords: EC; endometrial carcinoma; FIGO; Federation of Gynecology and Obstetrics; MRI; magnetic resonance imaging; CE; contrast-enhanced; T1-W; T1-weighted; T2-W; T2-weighted; DW; diffusion-weighted; T1-WI; T1-weighted imaging; T2-WI; T2-weighted imaging; DWI; di
A cut-off value of 2 cm in tumor size is of prognostic value in surgically treated FIGO stage IB cervical cancer
Keywords: Cervical carcinoma; Tumor size; Measurement; FIGO; Stage IB; Bulky disease
Polymorphisms in the promoter region of ESR2 gene and susceptibility to ovarian cancer
Keywords: ESR2; gene coding for estrogen receptor β; ER; estrogen receptor β; OR; odds ratio; SNP; single nucleotide polymorphism; FIGO; International Federation of Gynecology and Obstetrics; Ovarian cancer; Estrogen receptor beta; Single nucleotide polymorphism;
Postoperative outcomes of MR-invisible stage IB1 cervical cancer
Keywords: cervical cancer; FIGO; magnetic resonance imaging; outcome; radical hysterectomy; stage IB1;
Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: A histologic dichotomy
Keywords: CI; confidence interval; CSS; cause-specific survival; DFS; disease-free survival; EBRT; external-beam radiotherapy; EC; endometrial carcinoma; FIGO; International Federation of Gynecology and Obstetrics; G1/2EC; FIGO grade 1 and 2 endometrioid endometria
Human leukocyte antigen (HLA)-G and cervical cancer immunoediting: A candidate molecule for therapeutic intervention and prognostic biomarker?
Keywords: 3â²UTR; untranslated region; 5â²URR; upstream regulatory region; ADC; cervical adenocarcinoma; AGUS; atypical glandular cells; APC; antigen presenting cells; ATG; start codon; Cd; cytoplasmatic domain; CD; cluster of differentiation; CIN; cervical intra
Impact of tumor size on survival in cancer of the cervix and validation of stage IIA1 and IIA2 subdivisions
Keywords: Cervical cancer; Size; Staging; Prognostic; Survival; FIGO;
Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: An international collaborative meta-analysis
Keywords: Neoadjuvant; Chemotherapy; Surgery; Cervical cancer; CCR; concurrent chemoradiation; CENTRAL; Cochrane Central Register of Controlled Trials; CI; confidence interval; FIGO; International Federation of Gynaecology and Obstetrics; HR; hazard ratio; NCS; neo
No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population
Keywords: Serous ovarian neoplasms; fallopian tube neoplasms; salpingectomy; primary prevention; ASA; acetylsalicylic acid; BRCA; breast cancer; BTL; bilateral tubal ligation; CI; confidence interval; CS; Caesarean section; EOC; epithelial ovarian cancers; FIGO; In
Old versus new FIGO staging systems in predicting overall survival in patients with uterine leiomyosarcoma: A study of 86 cases
Keywords: Leiomyosarcoma; FIGO; Staging; Uterus; Survival
Cáncer de cérvix y endometrio
Keywords: Endometrio; Cérvix; FIGO; Cirugía; Radioterapia; QuimioterapiaEndometrial; Cervical; FIGO; Surgery; Radiotherapy; Chemotherapy
Need for a global obstetric fistula training strategy
Keywords: FIGO; Low-resource countries; Manual; Obstetric fistula; Surgery; Training;